Archaeosomes as adjuvants for combination vaccines.
The present study evaluated the potential of archaesomes, prepared from the total polar lipids extracted from Methanobrevibacter smithii, as adjuvants for combination (multivalent) vaccines. Groups of Balb/c mice were immunized subcutaneously at day 0 and 21 with one of the following vaccines: trivalent vaccine formulated by the simultaneous co-encapsulation of bovine serum albumine (BSA), ovalbumin (OVA) and hen egg lysozyme (HEL) into archaeosomes (CEC vaccine); an univalent archaeosome vaccine (UVE vaccine) containing either BSA, OVA or HEL; or an admixture vaccine (AMC vaccine) consisting of the three UVE vaccines. Serum specific antibody (IgG + M) responses were determined at day 32, 112 and 203, and specific IgG1 and IgG2a responses were determined at day 112. Mice immunized with the CEC of AMC vaccine developed strong and sustained specific antibody responses to all three antigens at a magnitude similar to those seen in control mice immunized with UVE vaccines. Moreover, the serum BSA-, OVA-, and HEL-specific IgG1 and IgG2a levels in the CEC and AMC immunized mice were overall comparable to those of the UVE immunized control mice. Boosting CEC and AMC vaccinated mice with antigens alone at day 203 elicited strong antibody memory responses, comparable to those in the UVE vaccinated groups. These results show that archaeosomes could be used as adjuvants in developing combination vaccines.
Patel
Girishchandra B
GB
Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario K1A 0R6, Canada. girish.patel@nrc-cnrc.gc.ca
Zhou
Hongyan
H
KuoLee
Rhonda
R
Chen
Wangxue
W
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D002417:Cattle; D002645:Chickens; D005260:Female; D007136:Immunoglobulins / Q000096:biosynthesis; D008081:Liposomes / Q000302:isolation & purification; D041581:Methanobrevibacter / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D017778:Vaccines, Combined / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D000941:Antigens; D007136:Immunoglobulins; D008081:Liposomes; D017778:Vaccines, Combined